Personalized Neoantigen Cancer Vaccine, Circulating Tumor DNA to Monitor Minimal Residual Disease in Breast Cancer October 22, 2026 admin@narisara 0 Research Topics Personalized Neoantigen Cancer Vaccine, Circulating Tumor DNA to Monitor Minimal Residual Disease in Breast Cancer Researchers Piriya Wongkongkathep Institute Chulalongkorn University Funding Health Systems Research Institute (HSRI) 2023 Timeline October 2023 – September 2024 Facebook Twitter Line